Bar-Shalom Rachel
Division of Positron Emission Tomography, Department of Nuclear Medicine, Rambam Health Care Campus, Haifa, 35254 Israel.
Radiol Clin North Am. 2007 Jul;45(4):677-88, vi-vii. doi: 10.1016/j.rcl.2007.05.006.
In spite of the high performance of 18F-fluorodeoxyglucose (FDG) PET for the evaluation of lymphoma, inherent limitations of this modality underscore the additional value of PET/CT as an important tool in the assessment of this disease. Accumulating data on the use of PET/CT in lymphoma indicate the contribution of hybrid imaging to improved interpretation accuracy of PET using FDG and CT. Knowledge of the normal and abnormal patterns of FDG-PET/CT imaging and their variability in patients with lymphoma is important to provide a comprehensive clinically significant interpretation that has an impact on patient management and potentially on outcome.
尽管18F-氟脱氧葡萄糖(FDG)PET在淋巴瘤评估方面具有高性能,但这种检查方式的固有局限性凸显了PET/CT作为评估该疾病的重要工具的附加价值。关于PET/CT在淋巴瘤中应用的越来越多的数据表明,融合成像有助于提高使用FDG的PET和CT的解读准确性。了解FDG-PET/CT成像的正常和异常模式及其在淋巴瘤患者中的变异性,对于提供全面的具有临床意义的解读非常重要,这会对患者管理产生影响,并可能影响治疗结果。